PARKSIDE GROUP PRACTICE — All Prescriptions & Medications — Page 8
Practice Code: H83015 | SOUTH CROYDON, CR2 6EX
Showing results 351-400 of 592
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 42 | 102 | £1.7K | +410.1% ▲ | |
| Vortioxetine | 41 | 1,456 | £1.4K | -40.9% ▼ |
| Erythromycin | 41 | 4,280 | £1.6K | +18.4% ▲ |
| Etonogestrel | 41 | 41 | £3.4K | +41.8% ▲ |
| 41 | 1,720 | £6.1K | +58.5% ▲ | |
| Ciprofloxacin | 40 | 622 | £70 | +0.3% vs avg |
| Alprostadil | 40 | 158 | £1.8K | +133.9% ▲ |
| Crotamiton | 40 | 5,140 | £299 | +140.6% ▲ |
| Permethrin | 40 | 3,540 | £1.2K | +6.2% ▲ |
| 40 | 1,520 | £897 | +276.0% ▲ | |
| Rivastigmine | 39 | 3,180 | £949 | -43.3% ▼ |
| Testosterone undecanoate | 39 | 40 | £3.5K | +53.6% ▲ |
| Bicalutamide | 39 | 543 | £40 | +20.6% ▲ |
| Ready to serve 1.5 kcal/ml milkshake (0913011) | 39 | 214.0K | £1.1K | -72.6% ▼ |
| Tizanidine hydrochloride | 39 | 2,492 | £244 | +47.2% ▲ |
| 39 | 400 | £597 | +53.5% ▲ | |
| 39 | 90 | £1.4K | +389.7% ▲ | |
| Biphasic isophane insulin | 38 | 270 | £1.1K | -65.9% ▼ |
| RtS 2.4 kcal/ml m/sk lower volume, higher protein (0913011) | 38 | 184.9K | £3.4K | -45.7% ▼ |
| Erythromycin | 37 | 1,420 | £683 | +172.5% ▲ |
| Norethisterone | 36 | 2,710 | £464 | -25.8% ▼ |
| Tacrolimus | 35 | 4,000 | £5.1K | +30.9% ▲ |
| Benzalkonium chloride | 35 | 9,750 | £218 | +205.1% ▲ |
| Oxycodone hydrochloride | 34 | 2,278 | £354 | -86.7% ▼ |
| Carmellose sodium | 34 | 2,550 | £294 | -47.5% ▼ |
| Other individually formulated bought in preparations | 33 | 113.5K | £577 | +1.0% vs avg |
| 33 | 330 | £318 | -16.3% ▼ | |
| 33 | 1,740 | £1.0K | +138.2% ▲ | |
| Sotalol hydrochloride | 32 | 2,744 | £78 | -54.5% ▼ |
| Fesoterodine fumarate | 32 | 966 | £81 | -18.9% ▼ |
| Clindamycin phosphate | 32 | 1,050 | £285 | +94.5% ▲ |
| 32 | 33 | £38 | +21.0% ▲ | |
| Labetalol hydrochloride | 31 | 2,548 | £347 | +36.5% ▲ |
| Diclofenac sodium | 31 | 1,351 | £215 | -38.9% ▼ |
| Aciclovir | 31 | 284 | £265 | +151.4% ▲ |
| Fluticasone furoate/vilanterol | 30 | 45 | £1.2K | -80.6% ▼ |
| Pizotifen malate | 30 | 1,820 | £83 | -63.6% ▼ |
| Azelastine hydrochloride | 30 | 312 | £237 | +152.4% ▲ |
| Menthol | 30 | 13.0K | £460 | +6.5% ▲ |
| 30 | 3,210 | £1.5K | +140.4% ▲ | |
| Pramipexole | 29 | 3,388 | £348 | -70.5% ▼ |
| Fosfomycin trometamol | 29 | 31 | £143 | +1.9% vs avg |
| Adapalene | 29 | 1,395 | £484 | +32.5% ▲ |
| Metronidazole | 29 | 1,385 | £491 | -22.8% ▼ |
| 29 | 297 | £890 | +112.6% ▲ | |
| Nizatidine | 28 | 1,708 | £841 | -18.6% ▼ |
| Bezafibrate | 28 | 1,952 | £346 | -48.0% ▼ |
| Phenobarbital | 28 | 1,856 | £148 | -8.9% ▼ |
| Ciclosporin (Eye Anti Inflammatory) | 28 | 1,950 | £4.7K | +12.9% ▲ |
| Diphenhydramine hydrochloride | 27 | 756 | £169 | +107.8% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.